BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15232201)

  • 1. Construction of recombinant polypeptides based on beta antigen C (Bac) protein & their usage for protection against group B streptococcal infection.
    Suvorov A; Ustinovitch I; Meringova L; Grabovskaya K; Leontieva G; Vorobieva E; Totolian A
    Indian J Med Res; 2004 May; 119 Suppl():228-32. PubMed ID: 15232201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity.
    Hedén LO; Frithz E; Lindahl G
    Eur J Immunol; 1991 Jun; 21(6):1481-90. PubMed ID: 2044657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant metalloprotease antigen of Vibrio vulnificus elicits protective antibodies in a murine model.
    Chen YC; Chang CC; Chang SY; Su JH
    Lett Appl Microbiol; 2010 Feb; 50(2):168-72. PubMed ID: 20002577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity of the C protein beta-antigen gene and its upstream regions within clonally related groups of type Ia and Ib group B streptococci.
    Nagano N; Nagano Y; Nakano R; Okamoto R; Inoue M
    Microbiology (Reading); 2006 Mar; 152(Pt 3):771-778. PubMed ID: 16514156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Escherichia coli-Enterococcus faecalis shuttle vector as a tool for the construction of a group B Streptococcus heterologous mutant expressing the beta antigen (Bac) of the C protein complex.
    Kreikemeyer B; Jerlström PG
    FEMS Microbiol Lett; 1999 Nov; 180(2):255-62. PubMed ID: 10556720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection.
    Batzloff M; Yan H; Davies M; Hartas J; Good M
    Indian J Med Res; 2004 May; 119 Suppl():104-7. PubMed ID: 15232173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci.
    Jerlström PG; Talay SR; Valentin-Weigand P; Timmis KN; Chhatwal GS
    Infect Immun; 1996 Jul; 64(7):2787-93. PubMed ID: 8698509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice.
    Huang D; Zhu H; Lin H; Xu J; Lu C
    Berl Munch Tierarztl Wochenschr; 2012; 125(3-4):144-52. PubMed ID: 22515033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
    Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
    J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunogenicity of an anti-caries vaccine encoding a cell-surface protein antigen of Streptococcus mutans by intranasal DNA prime-protein boost immunization.
    Li Y; Jin J; Yang Y; Bian Z; Chen Z; Fan M
    J Gene Med; 2009 Nov; 11(11):1039-47. PubMed ID: 19718694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental evaluation of recombinant polypeptides as Streptococcus Group B vaccine].
    Leont'eva GF; Suvorov AN; Meringova LF; Grabovskaia KB; Ustinovich IA; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):35-40. PubMed ID: 15881936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen.
    Takahashi I; Okahashi N; Matsushita K; Tokuda M; Kanamoto T; Munekata E; Russell MW; Koga T
    J Immunol; 1991 Jan; 146(1):332-6. PubMed ID: 1984447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
    Larsson C; Holmgren J; Lindahl G; Bergquist C
    Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease.
    Buccato S; Maione D; Rinaudo CD; Volpini G; Taddei AR; Rosini R; Telford JL; Grandi G; Margarit I
    J Infect Dis; 2006 Aug; 194(3):331-40. PubMed ID: 16826481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice.
    Chanter N; Ward CL; Talbot NC; Flanagan JA; Binns M; Houghton SB; Smith KC; Mumford JA
    Microb Pathog; 1999 Sep; 27(3):133-43. PubMed ID: 10455004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.